Name | Recombinant Canine IFN-gamma Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 781-CG/CF |
Category | Protein |
Prices | $289.00 |
Sizes | 50 µg |
Species Reactivities | Dog |
Nature | Recombinant |
Source | E. coli -derived Gln24-Lys166, with an N-terminal Met |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its anti-viral activity on A‑72 canine fibroma cells infected with vesicular stomatitis virus (VSV). The ED 50 for this effect is 0.3-1.5 ng/mL. |
Endotoxin | <0.01 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | P42161 |
Gene | IFNG |
Sequence | Met |
Supplier Page | Shop |
Wheat WH, Chow L, Kurihara JN, Regan DP, Coy JW, Webb TL, Dow SW. Stem Cells Dev. 2017 Feb 15;26(4):249-262.
Petitdidier E, Pagniez J, Papierok G, Vincendeau P, Lemesre JL, Bras-Goncalves R. PLoS Negl Trop Dis. 2016 May 25;10(5):e0004614. doi:
Lemesre JL, Holzmuller P, Goncalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Vaccine. 2007 May 22;25(21):4223-34. Epub 2007 Mar 15.
Lemesre JL, Holzmuller P, Cavaleyra M, Goncalves RB, Hottin G, Papierok G. Vaccine. 2005 Apr 22;23(22):2825-40.
Fujiwara RT, Loukas A, Mendez S, Williamson AL, Bueno LL, Wang Y, Samuel A, Zhan B, Bottazzi ME, Hotez PJ, Bethony JM. Vaccine. 2006 Jan 23;24(4):501-9. Epub 2005 Aug 15.